Tenax Therapeutics (TENX) Change in Receivables (2022 - 2025)
Tenax Therapeutics (TENX) reported Change in Receivables of -$1.2 million for Q1 2025, down 6900.0% on a YoY basis from $18000.0 in Q1 2024, and down 439.37% sequentially from $360670.0 in Q4 2024.
Tenax Therapeutics (TENX) Change in Receivables (2022 - 2025) Analysis & Trends
Tenax Therapeutics (TENX) has 4 years of Change in Receivables data on file, last reported at -$1.2 million in Q1 2025.
- For the quarter ending Q1 2025, Change in Receivables fell 6900.0% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2025 stood at -$1.3 million (down 332.64% YoY), and the FY2024 full-year result was -$58000.0, down 118.95% from the prior year.
- Change in Receivables slipped to -$1.2 million in Q1 2025, from $360670.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $963079.0 in Q4 2022 to a low of -$1.4 million in Q3 2022.
- A 4-year average of -$126439.5 and a median of -$36834.0 in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables soared 1079.18% in 2024 and slumped 6900.0% in 2025, its largest moves.
- Tracing TENX's Change in Receivables over 4 years: stood at $963079.0 in 2022, then sank by 103.82% to -$36834.0 in 2023, then soared by 1079.18% to $360670.0 in 2024, then slumped by 439.37% to -$1.2 million in 2025.
- Business Quant data shows TENX's Change in Receivables at -$1.2 million in Q1 2025, $360670.0 in Q4 2024, and $240931.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -1.22 Mn |
| Mar 31, 2025 | -1.22 Mn |
| Dec 31, 2024 | 360,670.00 |
| Dec 31, 2024 | 360,670.00 |
| Sep 30, 2024 | 240,931.00 |
| Sep 30, 2024 | 240,931.00 |
| Jun 30, 2024 | -677,601.00 |
| Jun 30, 2024 | -677,601.00 |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | -36,834.00 |
| Dec 31, 2023 | -36,834.00 |
| Sep 30, 2023 | 782,483.00 |
| Sep 30, 2023 | 782,483.00 |
| Jun 30, 2023 | -204,847.00 |
| Jun 30, 2023 | -204,847.00 |
| Mar 31, 2023 | -234,802.00 |
| Mar 31, 2023 | -234,802.00 |
| Dec 31, 2022 | 963,079.00 |
| Dec 31, 2022 | 963,079.00 |